Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.

We continue to work to fulfill our mission, and believe that Education is Medicine, perhaps more now than ever. Empowering you to be a partner in your medical care through education about treatment options is an absolute necessity. We are honored to be that platform for you.

We are excited about what the next year will bring, with new programs in the works, providing up to date information in the rapidly changing world of medicine. We continue to provide critical educational information to enable patients, families and caregivers to discuss management options with their medical team.
We don't hold golf tournaments or galas to support our work, we depend on your support during our yearly End of Year Appeal. Please consider supporting us again this year. We need your support so that we can continue to provide the most current and emerging treatment options for cancer patients.

Please ~ take this time to donate. Click here to donate online.
Please feel free to offer comments and raise questions in our
discussion forums.
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
Biomarkers are genetic mutations (like EGFR, ALK, KRAS, BRAF) or protein levels (like PD-L1) in tumor cells that help guide personalized treatment, especially NSCLC, directing patients to targeted therapies or immunotherapies...
Hi Stan! So good to hear from you. I'm sorry for the late response. I too have been out of town with family and missed your post, probably because I was...
It is so good to hear from you! And I am so happy to hear that your holidays have been good and that you are doing well. It sounds like your...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components: